Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis-Reference-Cited by-同舟云学术

Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis

Published:2005-01 Issue:4 Volume:12 Page:210-215
ISSN:1350-6129
Container-title:Amyloid
language:en
Short-container-title:Amyloid

Author:

Akar Harun,Seldin David C.,Magnani Barbarajean,O'Hara Carl,Berk John L.,Schoonmaker Christopher,Cabral Howard,Dember Laura M.,Sanchorawala Vaishali,Connors Lawreen H.,Falk Rodney H.,Skinner Martha

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/13506120500352339

Reference15 articles.

1. Amyloid Fibril Proteins: Proof of Homology with Immunoglobulin Light Chains by Sequence Analyses

2. The Systemic Amyloidoses

3. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis

4. High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibodies gone bad – the molecular mechanism of light chain amyloidosis;The FEBS Journal;2022-02-17

2. Recent developments in the treatment of amyloidosis;Drug Delivery Systems for Metabolic Disorders;2022

3. Screening Tests for Early Diagnosis of Multiple Myeloma and Related Plasma Cell Disorders;The Korean Journal of Medicine;2021-10-01

4. Evaluation of two serum free light chain quantitation methods, Freelite and Seralite, in the clinical laboratory with a view to switching immunoassay;Clinica Chimica Acta;2020-11

5. Outcomes of patients with AL amyloidosis and low serum free light chain levels at diagnosis;Amyloid;2018-07-03